Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Annual economic cost...

    Annual economic cost of Bidi smoking in India is INR 805.5 billion : BMJ

    Written by Vinay Singh singh Published On 2018-12-22T19:28:11+05:30  |  Updated On 22 Dec 2018 7:28 PM IST
    Annual economic cost of Bidi smoking in India is INR 805.5 billion : BMJ
    According to a Research paper published in BMJ, Total annual economic cost of Bidi smoking is INR 805.5 billion in India. Costs are estimated under the following heads: (1) direct medical expenditure of treating diseases; (2) indirect morbidity costs and (3) indirect mortality costs of premature deaths.

    Bidis produce equal or higher levels of nicotine, tar, and other toxic chemicals compared to conventional cigarettes. Their consumption and market penetration is spreading at a very high pace. Bidi is very popular in India, accounting for most (81%) of the tobacco smoked and 72 million regular users over the age of 15.


    According to research published in the journal Tobacco Control, Bidi smoking cost India 805.5 billion rupees in ill health and early deaths in 2017 alone. One can now easily figure out the disastrous effect of smoking bidi.


    Bidi smoking is implicated in several types of cancer, tuberculosis, and various long-term lung conditions. But despite its impact on the nation's health, it has been taxed at a rate that is a fraction of that applied to cigarettes, says the researcher.


    Read Also: Quitting smoking within five years, lowers heart attack risk by 38%


    The total annual economic costs of bidi smoking amount to approximately 0.5% of India’s gross domestic product, while the excise tax revenue from bidi is only half a percent of its economic costs. The direct medical costs of bidi smoking amount to 2.24% of total health expenditure.


    Direct costs-tests, drugs, doctors' fees, hospital stays, and transport-make up around a fifth of this total (just under 21%; INR 168.7 bn), with the remainder made up of indirect costs-accommodation for relatives/carers and loss of household income (INR 811.2 bn).


    As a result, nearly one in five households in India faces "catastrophic expenditures" due to healthcare costs, with more than 63 million people pushed into poverty.


    Read Aso: Hookah smoking unsafe, impairs blood vessel function


    "Diseases associated with bidi smoking add to this, potentially pushing more people into poverty," the author writes, suggesting that about 15 million face poverty because of spending on tobacco and associated health costs and expenditure on tobacco also crowds out expenditure on food and education in India, especially among the poor"


    The author calls for a tax hike to curb the increasing rate of bidi smoking in India and opined that allowing bidi consumption to continue unhindered would make income distribution even more regressive, as the poor will continue to bear a disproportionately large share of economic costs from bidi smoking due to their higher bidi smoking prevalence.


    For full information log on to http://dx.doi.org/10.1136/tobaccocontrol-2018-054493

    bidibidisBMJchemicalsconsumptioncostcostsdirect medical expenditureeconomiceconomic costexpenditureHealthin Indiaindirectindirect mortality costs of premature deathsINR 805.5 billionMorbidityNicotinesmokingtartaxTobacco Controltotaltoxic
    Source : With inputs from the journal Tobacco Control

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Vinay Singh singh
    Vinay Singh singh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok